Clinical and Analytical Performance of a Novel Point-of-Care High-Sensitivity Cardiac Troponin I Assay
Key result
The hs-cTnI-SPINCHIP POC test matches central lab assays for MI diagnosis, achieving 0.94 AUC.
- 95% CI 0.92-0.95
- P=0.907
- n=1,102
Why the study?
Point-of-care high-sensitivity cardiac troponin assays may further accelerate the diagnosis of myocardial infarction, leading investigators to evaluate the novel hs-cTnI-SPINCHIP point-of-care test.
Population
1,102 adult ED patients presenting with acute chest discomfort
Comparison
Novel hs-cTnI-SPINCHIP POC test vs established central laboratory assays
Design
International multicenter diagnostic study
Authors
Discussion
Loading...
Member takes
Key expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
AJAllan JaffeCardiologist, Mayo Clinic, Rochester
“One thing we know is that if you use the central lab and get a value that just doesn't make sense, we have all kinds of ways to troubleshoot it. We are not yet at the point where we understand [how to do that] with these point-of-care assays. I don't think it's unsolvable, but it is a concern.”
“The novel Point-of-Care SpinChip high-sensitivity cardiac Troponin I test demonstrated comparable diagnostic performance with the best-validated central laboratory assays. The results are impressive and very good news for both patients and physicians.”
“When comparing our data to previously published data on other POC hs-cTnI assays, we found that the efficacy of the POC hs-cTnI SpinChip 0/1-hour algorithm—measured by the number of patients who could be triaged for rule-in and rule-out—was higher than that of other POC hs-cTnI assays.”
Implication
Diagnostic study demonstrates robust analytical precision for a novel point-of-care troponin I assay in emergency patients, highlighting its potential for rapid myocardial infarction triage.
Key Points
- To evaluate the analytical characteristics and clinical diagnostic concordance of a novel point-of-care high-sensitivity cardiac troponin I assay in comparison with standard central laboratory platforms.
- Assessed analytical specifications including limit of detection, 20% coefficient of variation limits, and assay precision across clinically relevant concentrations.
- Evaluated clinical concordance and analytical correlation using paired patient samples tested on the point-of-care system and established central laboratory analyzers.
- The point-of-care platform achieved analytical sensitivity and precision thresholds consistent with expert guidelines for high-sensitivity cardiac troponin assays.
- Quantitative troponin measurements showed high correlation with central laboratory reference assays alongside significantly reduced sample-to-result turnaround times.
Study Design
Type
Observational (n=1,102)
Multicenter
Yes
PICO
P
Population
1,102 adult patients presenting with acute chest discomfort to the emergency department evaluated for myocardial infarction.
E
Exposure / Comparator
hs-cTnI-SPINCHIP POC test vs hs-cTnI-Architect and hs-cTnT Elecsys central laboratory assays
O
Primary Outcome
Discriminatory performance for myocardial infarction (Area under the receiver-operating characteristic curve) (0.92-0.95), p=0.907
Main Result
Absolute Event Rate: 0.94% vs 0.94%
p-value: p=0.907
Cite This Study
Koechlin et al. (2024) conducted an observational in Acute chest discomfort / suspected myocardial infarction (n=1,102). hs-cTnI-SPINCHIP POC test vs. hs-cTnI-Architect and hs-cTnT Elecsys central laboratory assays was evaluated on Discriminatory performance for myocardial infarction (Area under the receiver-operating characteristic curve) (95% CI 0.92-0.95, p=0.907). The hs-cTnI-SPINCHIP POC test demonstrated high diagnostic accuracy for myocardial infarction (AUC 0.94; 95% CI 0.92-0.95), comparable to established central laboratory assays.